Breast Reconstruction Market involves surgical procedures that recreate or reshape breasts after mastectomy or lumpectomy leading to breast disfigurement. These procedures help to restore symmetrical breasts and alleviate psychological stress associated with breast removal. Breast reconstruction is primarily performed using breast implants or autologous tissue flaps from other parts of the body. Breast implants provide immediate size and shape improvement but may require revision surgeries. Tissue flap procedures utilize patient's own tissue to create longer lasting breast shapes with a natural feel, reducing infection and rejection risks compared to implants. The global Breast reconstruction Market is estimated to be valued at US$ 901.3 Mn in 2023 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends in the breast reconstruction market is the increasing adoption of mastopexy procedures for breast lift without implants. This procedure involves surgical removal of excess skin and tightening of the breast tissue and nipple position to make breasts look fuller. Mastopexy allows women who have undergone lumpectomy or weight fluctuation to reshape breasts without implants, addressing the issue of capsular contracture and implant leakage. Another trend is the use of acellular dermal matrices as implant-based tissue expanders. These matrices provide adjustable, biocompatible scaffold to support and stabilize breast implants. They reduce implant rippling and allow for implant placement in tight, damaged breast tissue pockets.
Porter’s Analysis
Threat of new entrants: The breast reconstruction market is consolidated and capital intensive nature of this market limits the threat of new entrants. Bargaining power of buyers: The bargaining power of buyers is moderate given the availability of product substitutes. Bargaining power of suppliers: Suppliers have moderate bargaining power due to the availability of substitute raw materials. Threat of new substitutes: Threat of new substitutes is low as breast reconstruction procedures require expertise of experienced surgeons. Competitive rivalry: The market is dominated by few major players and witnessing high competition between leading manufacturers.
Key Takeaways
The Global Breast Reconstruction Market Demand is expected to witness high growth.
North America is dominating the market and is projected to grow at a significant rate during the forecast period. Key factors such as increasing number of breast cancer cases, technical advancements in breast reconstruction procedures, and growing awareness about breast reconstruction alternatives have been driving the North America market. Europe is the fastest growing market globally and is expected to offer lucrative opportunities owing to increasing healthcare expenditure, rising geriatric population, and improving reimbursement policies.
Key players operating in the breast reconstruction market are Polytech Health & Aesthetics GmbH, Allergan, Mentor Worldwide LLC (Johnson & Johnson), Sientra Inc., GC Aesthetics, RTI Surgical, Inc., Groupe Sebbin SAS, Integra LifeSciences, and Wanhe. These companies are focusing on various strategies such as new product launches, mergers & acquisitions and geographical expansions to gain higher market share. For instance, in February 2020, GC Aesthetics launched two new breast implants - ELLE and NOVELLA for breast reconstruction and augmentation.
For more details on the report, Read- https://www.insightprobing.com/breast-reconstruction-market-size-and-share/
Get more insights on this topic: https://careersplay.com/unlocking-of-the-symphony-of-cell-signals-navigating-the-landscape
Comments
0 comment